Acute cholangitis is encountered commonly in critically ill, often elderly, patients. The most common causes of cholangitis include choledocholithiasis, biliary strictures, and infection from previous endoscopic, percutaneous, or surgical intervention of the biliary tract. Rare causes of acute cholangitis in the United States include sclerosing cholangitis and recurrent pyogenic cholangitis, the latter predominantly occurring in immigrants of Asian descent. Multidisciplinary management of these conditions is essential, with intensivists, surgeons, diagnostic radiologists, interventional radiologists, gastroenterologists, endoscopists, and infectious disease physicians typically involved in the care of these patients. In this paper intended for intensivists predominantly, we will review the imaging findings and radiologic interventional management of critically ill patients with acute cholangitis, primary and secondary sclerosing cholangitis, and recurrent pyogenic cholangitis.
KimuraYTakadaTKawaradaY, et al.Definitions, pathophysiology, and epidemiology of acute cholangitis and cholecystitis: Tokyo guidelines. J Hepatobiliary Pancreat Surg. 2007;14(1):15-26. doi:https://doi.org/10.1007/s00534-006-1152-y
2.
SahariaPCCameronJL. Clinical management of acute cholangitis. Surg Gynecol Obstet. 1976;142(3):369-372.
3.
AnZBrasethALSaharN. Acute cholangitis: Causes, diagnosis, and management. Gastroenterol Clin North Am. 2021;50(2):403-414. doi:https://doi.org/10.1016/j.gtc.2021.02.005
4.
ShanbhogueAKPTirumaniSHPrasadSRFasihNMcInnesM. Benign biliary strictures: A current comprehensive clinical and imaging review. AJR Am J Roentgenol. 2011;197(2):W295-W306. doi:https://doi.org/10.2214/AJR.10.6002
KiriyamaSKozakaKTakadaT, et al.Tokyo Guidelines 2018: Diagnostic criteria and severity grading of acute cholangitis (with videos). J Hepato-Biliary-Pancreat Sci. 2018;25(1):17-30. doi:https://doi.org/10.1002/jhbp.512
7.
CsendesADiazJCBurdilesPMaluendaFMoralesE. Risk factors and classification of acute suppurative cholangitis. Br J Surg. 1992;79(7):655-658. doi:https://doi.org/10.1002/bjs.1800790720
8.
HonickmanSPMuellerPRWittenbergJ,et al.Ultrasound in obstructive jaundice: Prospective evaluation of site and cause. Radiology. 1983;147(2):511-515. doi:https://doi.org/10.1148/radiology.147.2.6836132
9.
GuptaPGuptaJKumarMP. Imaging in obstructive jaundice: What a radiologist needs to know before doing a percutaneous transhepatic biliary drainage. J Clin Interv Radiol ISVIR. 2020;4(01):31-37. doi:https://doi.org/10.1055/s-0039-3401327
SugiyamaMAtomiY. Endoscopic ultrasonography for diagnosing choledocholithiasis: A prospective comparative study with ultrasonography and computed tomography. Gastrointest Endosc. 1997;45(2):143-146. doi:https://doi.org/10.1016/s0016-5107(97)70237-2
YehBMLiuPSSotoJACorveraCAHussainHK. MR Imaging and CT of the biliary tract. Radiogr Rev Publ Radiol Soc N Am Inc. 2009;29(6):1669-1688. doi:https://doi.org/10.1148/rg.296095514
15.
MajeedAWRossBJohnsonAGReedMW. Common duct diameter as an independent predictor of choledocholithiasis: Is it useful?Clin Radiol. 1999;54(3):170-172. doi:https://doi.org/10.1016/s0009-9260(99)91008-5
16.
HekimogluKUstundagYDusakA,et al.MRCP Vs. ERCP in the evaluation of biliary pathologies: Review of current literature. J Dig Dis. 2008;9(3):162-169. doi:https://doi.org/10.1111/j.1751-2980.2008.00339.x
17.
RomagnuoloJBardouMRahmeEJosephLReinholdCBarkunAN. Magnetic resonance cholangiopancreatography: A meta-analysis of test performance in suspected biliary disease. Ann Intern Med. 2003;139(7):547-557. doi:https://doi.org/10.7326/0003-4819-139-7-200310070-00006
18.
CuiXYChenHW. Role of diffusion-weighted magnetic resonance imaging in the diagnosis of extrahepatic cholangiocarcinoma. World J Gastroenterol. 2010;16(25):3196-3201. doi:https://doi.org/10.3748/wjg.v16.i25.3196
19.
ParkMSKimTKKimKW, et al.Differentiation of extrahepatic bile duct cholangiocarcinoma from benign stricture: Findings at MRCP versus ERCP. Radiology. 2004;233(1):234-240. doi:https://doi.org/10.1148/radiol.2331031446
20.
KurdiaKCIrrinkiSSiddharthBGuptaVLalAYadavTD. Percutaneous transhepatic cholangiography in the era of magnetic resonance cholangiopancreatography: A prospective comparative analysis in preoperative evaluation of benign biliary stricture. JGH Open Open Access J Gastroenterol Hepatol. 2021;5(7):820-824. doi:https://doi.org/10.1002/jgh3.12594
KwanKELShelatVGTanCH. Recurrent pyogenic cholangitis: A review of imaging findings and clinical management. Abdom Radiol N Y.2017;42(1):46-56. doi:https://doi.org/10.1007/s00261-016-0953-y
23.
AndersonSWLuceyBCVargheseJCSotoJA. Accuracy of MDCT in the diagnosis of choledocholithiasis. Am J Roentgenol. 2006;187(1):174-180. doi:https://doi.org/10.2214/AJR.05.0459
24.
NeitlichJDTopazianMSmithRCGuptaABurrellMIRosenfieldAT. Detection of choledocholithiasis: Comparison of unenhanced helical CT and endoscopic retrograde cholangiopancreatography. Radiology. 1997;203(3):753-757. doi:https://doi.org/10.1148/radiology.203.3.9169700
25.
AndersonSWRhoESotoJA. Detection of biliary duct narrowing and choledocholithiasis: Accuracy of portal venous phase multidetector CT. Radiology. 2008;247(2):418-427. doi:https://doi.org/10.1148/radiol.2472070473
26.
RöschTMeiningAFrühmorgenS, et al.A prospective comparison of the diagnostic accuracy of ERCP, MRCP, CT, and EUS in biliary strictures. Gastrointest Endosc. 2002;55(7):870-876. doi:https://doi.org/10.1067/mge.2002.124206
27.
MayumiTOkamotoKTakadaT, et al.Tokyo Guidelines 2018: Management bundles for acute cholangitis and cholecystitis. J Hepato-Biliary-Pancreat Sci. 2018;25(1):96-100. doi:https://doi.org/10.1002/jhbp.519
28.
YoonSBJeonTYMoonSH,et al.Effectiveness and complication rates of percutaneous transhepatic fluoroscopy-guided management of common bile duct stones: A single-arm meta-analysis. Eur Radiol. 2023;33(11):7398-7407. doi:https://doi.org/10.1007/s00330-023-09846-z
IqbalUKharaHSHuY,et al.Emergent versus urgent ERCP in acute cholangitis: A systematic review and meta-analysis. Gastrointest Endosc. 2020;91(4):753-760.e4. doi:https://doi.org/10.1016/j.gie.2019.09.040
35.
KhamaysiITahaR. ERCP For severe acute cholangitis: The earlier, the better. Turk J Gastroenterol Off J Turk Soc Gastroenterol. 2020;31(1):78-79. doi:https://doi.org/10.5152/tjg.2020.19103
36.
ZhuYTuJZhaoYJingJDongZPanW. Association of timing of biliary drainage with clinical outcomes in severe acute cholangitis: A retrospective cohort study. Int J Gen Med. 2021;14:2953-2963. doi:https://doi.org/10.2147/IJGM.S315306
37.
LeeFOhanianERheemJLaineLCheKKimJJ. Delayed endoscopic retrograde cholangiopancreatography is associated with persistent organ failure in hospitalised patients with acute cholangitis. Aliment Pharmacol Ther. 2015;42(2):212-220. doi:https://doi.org/10.1111/apt.13253
38.
KhashabMATariqATariqU, et al.Delayed and unsuccessful endoscopic retrograde cholangiopancreatography are associated with worse outcomes in patients with acute cholangitis. Clin Gastroenterol Hepatol.2012;10(10):1157-1161. doi:https://doi.org/10.1016/j.cgh.2012.03.029
39.
NavaneethanUGutierrezNGJegadeesanR,et al.Factors predicting adverse short-term outcomes in patients with acute cholangitis undergoing ERCP: A single center experience. World J Gastrointest Endosc. 2014;6(3):74-81. doi:https://doi.org/10.4253/wjge.v6.i3.74
40.
VenkatanarasimhaNDamodharanKGognaA,et al.Diagnosis and management of complications from percutaneous biliary tract interventions. RadioGraphics. 2017;37(2):665-680. doi:https://doi.org/10.1148/rg.2017160159
NomuraTShiraiYHatakeyamaK. Bacteribilia and cholangitis after percutaneous transhepatic biliary drainage for malignant biliary obstruction. Dig Dis Sci. 1999;44(3):542-546. doi:https://doi.org/10.1023/a:1026653306735
43.
vanSonnenbergECasolaGCubberleyDA, et al.Oriental cholangiohepatitis: Diagnostic imaging and interventional management. AJR Am J Roentgenol. 1986;146(2):327-331. doi:https://doi.org/10.2214/ajr.146.2.327
44.
PedersoliFSchröderAZimmermannM, et al.Percutaneous transhepatic biliary drainage (PTBD) in patients with dilated vs. Nondilated bile ducts: Technical considerations and complications. Eur Radiol. 2021;31(5):3035-3041. doi:https://doi.org/10.1007/s00330-020-07368-6
45.
ShiauELLiangHLLinYH,et al.The complication of hepatic artery injuries of 1,304 percutaneous transhepatic biliary drainage in a single institute. J Vasc Interv Radiol JVIR. 2017;28(7):1025-1032. doi:https://doi.org/10.1016/j.jvir.2017.03.016
46.
HarbinWPMuellerPRFerrucciJT. Transhepatic cholangiography: Complicatons and use patterns of the fine-needle technique: A multi-institutional survey. Radiology. 1980;135(1):15-22. doi:https://doi.org/10.1148/radiology.135.1.6987704
47.
OzturkKNasOFSoyluEHacikurtKErdoganC. Opacification of nondilated bile ducts through the gallbladder as an aid to percutaneous transhepatic biliary drainage. Diagn Interv Imaging. 2018;99(4):231-236. doi:https://doi.org/10.1016/j.diii.2017.11.001
48.
vanSonnenbergED’AgostinoHBCasolaGVarneyRRTaggartSCMaySR. The benefits of percutaneous cholecystostomy for decompression of selected cases of obstructive jaundice. Radiology. 1990;176(1):15-18. doi:https://doi.org/10.1148/radiology.176.1.2191363
49.
KühnJPBusemannALerchMMHeideckeCDHostenNPulsR. Percutaneous biliary drainage in patients with nondilated intrahepatic bile ducts compared with patients with dilated intrahepatic bile ducts. AJR Am J Roentgenol. 2010;195(4):851-857. doi:https://doi.org/10.2214/AJR.09.3461
50.
JungGSKimYJYunJH,et al.Percutaneous transcholecystic removal of common bile duct stones: Case series in 114 patients. Radiology. 2019;290(1):238-243. doi:https://doi.org/10.1148/radiol.2018173043
KhoshpouriPHabibabadiRRHazhirkarzarB, et al.Imaging features of primary sclerosing cholangitis: From diagnosis to liver transplant follow-up. RadioGraphics. 2019;39(7):1938-1964. doi:https://doi.org/10.1148/rg.2019180213
53.
ScheppachWDrugeGWittenbergG,et al.Sclerosing cholangitis and liver cirrhosis after extrabiliary infections: Report on three cases. Crit Care Med. 2001;29(2):438-441. doi:https://doi.org/10.1097/00003246-200102000-00042
54.
MartinsPVerdelho MachadoM. Secondary sclerosing cholangitis in critically ill patients: An underdiagnosed entity. GE Port J Gastroenterol. 2020;27(2):103-114. doi:https://doi.org/10.1159/000501405
55.
VoigtländerTNegmAASchneiderAS,et al.Secondary sclerosing cholangitis in critically ill patients: Model of end-stage liver disease score and renal function predict outcome. Endoscopy. 2012;44(11):1055-1058. doi:https://doi.org/10.1055/s-0032-1325733
56.
GelbmannCMRümmelePWimmerM, et al.Ischemic-like cholangiopathy with secondary sclerosing cholangitis in critically ill patients. Am J Gastroenterol. 2007;102(6):1221-1229. doi:https://doi.org/10.1111/j.1572-0241.2007.01118.x
57.
LeonhardtSVeltzke-SchliekerWAdlerA,et al.Secondary sclerosing cholangitis in critically ill patients: Clinical presentation, cholangiographic features, natural history, and outcome: A series of 16 cases. Medicine (Baltimore).2015;94(49):e2188. doi:https://doi.org/10.1097/MD.0000000000002188
58.
LeonhardtSVeltzke-SchliekerWAdlerA, et al.Trigger mechanisms of secondary sclerosing cholangitis in critically ill patients. Crit Care Lond Engl. 2015;19(1):131. doi:https://doi.org/10.1186/s13054-015-0861-5
59.
LaurentLLemaitreCMinelloA, et al.Cholangiopathy in critically ill patients surviving beyond the intensive care period: A multicentre survey in liver units. Aliment Pharmacol Ther. 2017;46(11–12):1070-1076. doi:https://doi.org/10.1111/apt.14367
60.
VoigtländerTJaeckelELehnerFMannsMPLankischTO. Liver transplantation for critically Ill patients with secondary sclerosing cholangitis: Outcome and complications. Liver Transpl.2015;21(10):1295-1299. doi:https://doi.org/10.1002/lt.24192
61.
AronsohnAJensenD. Hepatobiliary manifestations of critically ill and postoperative patients. Clin Liver Dis. 2011;15(1):183-197. doi:https://doi.org/10.1016/j.cld.2010.09.004
62.
BrienzaNDalfinoLCinnellaGDieleCBrunoFFioreT. Jaundice in critical illness: Promoting factors of a concealed reality. Intensive Care Med. 2006;32(2):267-274. doi:https://doi.org/10.1007/s00134-005-0023-3
63.
StrnadPTackeFKochATrautweinC. Liver - guardian, modifier and target of sepsis. Nat Rev Gastroenterol Hepatol. 2017;14(1):55-66. doi:https://doi.org/10.1038/nrgastro.2016.168
64.
MorganMAKhotRSundaramKM,et al.Primary sclerosing cholangitis: Review for radiologists. Abdom Radiol N Y. 2023;48(1):136-150. doi:https://doi.org/10.1007/s00261-022-03655-6
65.
DaveMElmunzerBJDwamenaBAHigginsPDR. Primary sclerosing cholangitis: Meta-analysis of diagnostic performance of MR cholangiopancreatography. Radiology. 2010;256(2):387-396. doi:https://doi.org/10.1148/radiol.10091953
66.
HiraiIIshiyamaSFuseA,et al.Primary sclerosing cholangitis successfully treated by resection of the confluence of the hepatic duct. J Hepatobiliary Pancreat Surg. 2001;8(2):169-173. doi:https://doi.org/10.1007/s005340170042
67.
SanerFHFreyAStübenBO, et al.Transplantation for primary sclerosing cholangitis: Outcomes and recurrence. J Clin Med. 2023;12(10):3405. doi:https://doi.org/10.3390/jcm12103405
68.
CampsenJZimmermanMATrotterJF,et al.Clinically recurrent primary sclerosing cholangitis following liver transplantation: A time course. Liver Transpl.2008;14(2):181-185. doi:https://doi.org/10.1002/lt.21313
69.
HeffernanEJGeogheganTMunkPLHoSGHarrisAC. Recurrent pyogenic cholangitis: From imaging to intervention. AJR Am J Roentgenol. 2009;192(1):W28-W35. doi:https://doi.org/10.2214/AJR.08.1104
70.
MuellerPRFerrucciJTvanSonnenbergE,et al.Obstruction of the left hepatic duct: Diagnosis and treatment by selective fine-needle cholangiography and percutaneous biliary drainage. Radiology. 1982;145(2):297-302. doi:https://doi.org/10.1148/radiology.145.2.6291093
71.
FederleMPCelloJPLaingFCJeffreyRB. Recurrent pyogenic cholangitis in Asian immigrants. Use of ultrasonography, computed tomography, and cholangiography. Radiology. 1982;143(1):151-156. doi:https://doi.org/10.1148/radiology.143.1.7063721
72.
RallsPWCollettiPMQuinnMFLapinSAMorrisULHallsJ. Sonography in recurrent oriental pyogenic cholangitis. AJR Am J Roentgenol. 1981;136(5):1010-1012. doi:https://doi.org/10.2214/ajr.136.5.1010
KimMJChaSWMitchellDGChungJJParkSChungJB. MR Imaging findings in recurrent pyogenic cholangitis. AJR Am J Roentgenol. 1999;173(6):1545-1549. doi:https://doi.org/10.2214/ajr.173.6.10584799
75.
ParkMSYuJSKimKW,et al.Recurrent pyogenic cholangitis: Comparison between MR cholangiography and direct cholangiography. Radiology. 2001;220(3):677-682. doi:https://doi.org/10.1148/radiol.2202001252
76.
HuangMHChenCHYangJC,et al.Long-term outcome of percutaneous transhepatic cholangioscopic lithotomy for hepatolithiasis. Am J Gastroenterol. 2003;98(12):2655-2662. doi:https://doi.org/10.1111/j.1572-0241.2003.08770.x
77.
Al-SukhniWGallingerSPratzerA, et al.Recurrent pyogenic cholangitis with hepatolithiasis–the role of surgical therapy in North America. J Gastrointest Surg.2008;12(3):496-503. doi:https://doi.org/10.1007/s11605-007-0398-2
78.
CoMPangSYWongKYIpWKYuenWK. Surgical management of recurrent pyogenic cholangitis: 10 years of experience in a tertiary referral centre in Hong Kong. HPB (Oxford).2014;16(8):776-780. doi:https://doi.org/10.1111/hpb.12185
